MOLECULAR DEVICES CORP (MDCC) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 323 transactions totaling $16.1M, demonstrating a bearish sentiment with -$16.1M in net insider flow. The most recent transaction on Mar 26, 2007 involved a transaction of 4,000 shares valued at $75.1K.
No significant insider buying has been recorded for MDCC in the recent period.
No significant insider selling has been recorded for MDCC in the recent period.
Based on recent SEC filings, insider sentiment for MDCC is bearish with an Insider Alignment Score of 0/100 and a net flow of -$16.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at MOLECULAR DEVICES CORP (MDCC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading MDCC stock, having executed 323 transactions in the past 90 days. The most active insider is Joseph D. Keegan (Executive), who has made 55 transactions totaling $26.5M.
Get notified when executives and directors at MDCC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 26, 2007 | Blaine Bowman A. | Executive | Option Exercise | 4,000 | $18.77 | $75.1K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Disposition | 4,000 | $35.50 | $142.0K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Option Exercise | 4,000 | $29.96 | $119.8K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Disposition | 4,000 | $35.50 | $142.0K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Option Exercise | 4,000 | $19.20 | $76.8K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Disposition | 4,000 | $N/A | $0 | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Option Exercise | 8,000 | $19.25 | $154.0K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Disposition | 10,000 | $35.50 | $355.0K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Option Exercise | 10,000 | $21.62 | $216.2K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Disposition | 16,500 | $35.50 | $585.8K | Large |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Option Exercise | 16,500 | $14.50 | $239.3K | |
| Mar 26, 2007 | Blaine Bowman A. | Executive | Disposition | 8,000 | $35.50 | $284.0K | |
| Mar 26, 2007 | Joseph Murray Robert | Executive | Disposition | 25,000 | $35.50 | $887.5K | Large |
| Mar 26, 2007 | Joseph Murray Robert | Executive | Option Exercise | 20,000 | $21.32 | $426.4K | |
| Mar 26, 2007 | Joseph Murray Robert | Executive | Disposition | 25,000 | $35.50 | $887.5K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 48 | $38.2M | 35.2% |
Exercise(M) | 100 | $32.6M | 30.0% |
Tender(U) | 14 | $21.7M | 20.0% |
Sale(S) | 158 | $16.1M | 14.8% |
Other(J) | 3 | $9.9K | 0.0% |
Insider selling pressure at MOLECULAR DEVICES CORP has increased, with 16 insiders executing 323 transactions across all time. Total sales of $16.1M significantly outpace purchases of $0, resulting in a net outflow of $16.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.